BRIEF|brief|JJ COMMUNICATION|communication|NN Inhibition|inhibition|NN of|of|IN Tumor|Tumor|NNP Growth|Growth|NNP Using|use|VBG Salmonella|salmonella|NN Expressing|express|VBG Fas|Fas|NNP Ligand|ligand|NN Markus|Markus|NNP Loeffler|Loeffler|NNP ,|,|, Gaelle|Gaelle|NNP Le'Negrate|Le'Negrate|NNP ,|,|, Maryla|Maryla|NNP Krajewska|Krajewska|NNP ,|,|, John|John|NNP C.|C.|NNP Reed|Reed|NNP Intravenous|Intravenous|NNP administration|administration|NN of|of|IN bacteria|bacterium|NNS leads|lead|VBZ to|to|IN their|they|PRP$ accumulation|accumulation|NN in|in|IN tumors|tumor|NNS and|and|CC to|to|IN sporadic|sporadic|JJ tumor|tumor|NN regression|regression|NN .|.|. 
We|we|PRP therefore|therefore|RB explored|explore|VBD the|the|DT hypothesis|hypothesis|NN that|that|IN Salmonella|Salmonella|NNP typhimurium|typhimurium|NN engineered|engineer|VBN to|to|TO express|express|VB the|the|DT proapoptotic|proapoptotic|JJ cytokine|cytokine|NN Fas|Fas|NNP ligand|ligand|NN (|(|-LRB- FasL|fasl|NN )|)|-RRB- would|would|MD exhibit|exhibit|VB enhanced|enhance|VBN antitumor|antitumor|JJ activity|activity|NN .|.|. 
Immunocompetent|immunocompetent|NN mice|mouse|NNS carrying|carry|VBG tumors|tumor|NNS derived|derive|VBN from|from|IN syngeneic|syngeneic|JJ murine|murine|JJ D2F2|d2f2|NN breast|breast|NN carcinoma|carcinoma|NN or|or|CC CT|ct|NN -|-|HYPH 26|26|CD colon|colon|NN carcinoma|carcinoma|NN cells|cell|NNS were|be|VBD treated|treat|VBN intravenously|intravenously|RB with|with|IN FasL|fasl|NN -|-|HYPH expressing|express|VBG S.|S.|NNP typhimurium|typhimurium|NN or|or|CC with|with|IN phosphate|phosphate|NN -|-|HYPH buffered|buffer|VBN saline|saline|NN (|(|-LRB- PBS|pbs|NN ;|;|: control|control|NN )|)|-RRB- .|.|. 
Treatment|treatment|NN with|with|IN FasL|fasl|NN -|-|HYPH expressing|express|VBG S.|S.|NNP typhimurium|typhimurium|NN inhibited|inhibit|VBN growth|growth|NN of|of|IN primary|primary|JJ tumors|tumor|NNS by|by|IN an|a|DT average|average|NN of|of|IN 59|59|CD %|%|NN for|for|IN D2F2|d2f2|NN tumors|tumor|NNS and|and|CC 82|82|CD %|%|NN for|for|IN CT|ct|NN -|-|HYPH 26|26|CD tumors|tumor|NNS (|(|-LRB- eg|eg|FW ,|,|, at|at|IN 25|25|CD days|day|NNS after|after|IN initial|initial|JJ treatment|treatment|NN ,|,|, mean|mean|VB volume|volume|NN of|of|IN PBS|pbs|NN -|-|HYPH treated|treat|VBN CT|ct|NN -|-|HYPH 26|26|CD colon|colon|NN carcinomas|carcinoma|NNS =|=|SYM 1385|1385|CD mm3|mm3|NN and|and|CC of|of|IN S.|S.|NNP typhimurium|typhimurium|NN FasL|fasl|NN -|-|HYPH treated|treat|VBN CT|ct|NN -|-|HYPH 26|26|CD tumors|tumor|NNS =|=|SYM 243|243|CD mm3|mm3|NN ,|,|, difference|difference|NN =|=|SYM 1142|1142|CD mm3|mm3|NN ,|,|, 95|95|CD %|%|NN confidence|confidence|NN interval|interval|NN =|=|SYM 800|800|CD mm3|mm3|NN to|to|IN 1484|1484|CD mm3|mm3|NN ,|,|, P|p|NN <|<|SYM .001|.001|CD )|)|-RRB- .|.|. 
Pulmonary|pulmonary|JJ D2F2|d2f2|NN metastases|metastase|NNS (|(|-LRB- as|as|IN measured|measure|VBN by|by|IN lung|lung|NN weight|weight|NN )|)|-RRB- were|be|VBD reduced|reduce|VBN by|by|IN 34|34|CD %|%|NN in|in|IN S.|S.|NNP typhimurium|typhimurium|NN FasL|fasl|NN -|-|HYPH treated|treat|VBN mice|mouse|NNS compared|compare|VBN with|with|IN PBS|pbs|NN -|-|HYPH treated|treat|VBN mice|mouse|NNS .|.|. 
FasL|fasl|NN -|-|HYPH expressing|express|VBG S.|S.|NNP typhimurium|typhimurium|NN had|have|VBD similar|similar|JJ effects|effect|NNS on|on|IN growth|growth|NN of|of|IN murine|murine|JJ B16|b16|NN melanoma|melanoma|NN tumors|tumor|NNS in|in|IN wild|wild|JJ -|-|HYPH type|type|NN mice|mouse|NNS but|but|CC not|not|RB in|in|IN lpr|lpr|NN /|/|HYPH lpr|lpr|NN mice|mouse|NNS ,|,|, which|which|WDT lack|lack|VBP Fas|Fas|NNP ,|,|, or|or|CC in|in|IN mice|mouse|NNS with|with|IN disrupted|disrupt|VBN host|host|NN inflammatory|inflammatory|JJ responses|response|NNS .|.|. 
Antitumor|antitumor|NN activity|activity|NN was|be|VBD achieved|achieve|VBN without|without|IN overt|overt|JJ toxicity|toxicity|NN .|.|. 
These|these|DT preclinical|preclinical|JJ results|result|NNS raise|raise|VBP the|the|DT possibility|possibility|NN that|that|IN using|use|VBG attenuated|attenuate|VBN S.|S.|NNP typhimurium|typhimurium|NN to|to|TO deliver|deliver|VB FasL|fasl|NN to|to|IN tumors|tumor|NNS may|may|MD be|be|VB an|a|DT effective|effective|JJ and|and|CC well|well|RB -|-|HYPH tolerated|tolerate|VBN therapeutic|therapeutic|JJ strategy|strategy|NN for|for|IN some|some|DT cancers|cancer|NNS .|.|. 
Plasmid|plasmid|NN pGEN206|pgen206|NN is|be|VBZ a|a|DT modiﬁed|modiﬁed|JJ form|form|NN of|of|IN pGEN222|pgen222|NN (|(|-LRB- 17|17|CD )|)|-RRB- ,|,|, in|in|IN which|which|WDT we|we|PRP exchanged|exchange|VBD the|the|DT parA|para|NN locus|locus|NN with|with|IN the|the|DT parM|parm|NN and|and|CC parR|parr|NN loci|locus|NNS and|and|CC introduced|introduce|VBD a|a|DT repA|repa|NN locus|locus|NN between|between|IN the|the|DT multiple|multiple|JJ cloning|cloning|NN sites|site|NNS and|and|CC the|the|DT origin|origin|NN of|of|IN replication|replication|NN .|.|. 
Cell|cell|NN -|-|HYPH containing|contain|VBG pellets|pellet|NNS and|and|CC cleared|clear|VBD culture|culture|NN supernatants|supernatant|NNS were|be|VBD tested|test|VBN for|for|IN CD8|cd8|NN --|--|: FasL|fasl|NN fusion|fusion|NN protein|protein|NN by|by|IN immunoblotting|immunoblotting|NN using|use|VBG anti-FasL|anti-fasl|JJ antibody|antibody|NN as|as|IN described|describe|VBN (|(|-LRB- 14|14|CD )|)|-RRB- .|.|. 
These|these|DT results|result|NNS demonstrated|demonstrate|VBD the|the|DT presence|presence|NN of|of|IN CD8|cd8|NN --|--|: FasL|fasl|NN in|in|IN both|both|CC the|the|DT bacterial|bacterial|JJ cells|cell|NNS and|and|CC the|the|DT culture|culture|NN supernatant|supernatant|NN (|(|-LRB- Figure|figure|NN 1|1|CD ,|,|, A|a|NN )|)|-RRB- .|.|. 
Attenuated|attenuate|VBN S.|S.|NNP typhimurium|typhimurium|NN preferentially|preferentially|RB accumulate|accumulate|VBP in|in|IN tumors|tumor|NNS (|(|-LRB- 1|1|CD --|--|, 3,19|3,19|CD )|)|-RRB- .|.|. 
To|to|TO test|test|VB the|the|DT in|in|FW vivo|vivo|FW antitumor|antitumor|NN activity|activity|NN of|of|IN FasL|fasl|NN -|-|HYPH expressing|express|VBG S.|S.|NNP typhimurium|typhimurium|NN ,|,|, we|we|PRP used|use|VBD mouse|mouse|NN cancer|cancer|NN models|model|NNS in|in|IN which|which|WDT mice|mouse|NNS were|be|VBD either|either|CC injected|inject|VBD subcutaneously|subcutaneously|RB with|with|IN murine|murine|JJ D2F2|d2f2|NN breast|breast|NN carcinoma|carcinoma|NN cells|cell|NNS (|(|-LRB- n|n|NN =|=|SYM 8|8|CD mice|mouse|NNS per|per|IN group|group|NN )|)|-RRB- or|or|CC murine|murine|JJ CT|ct|NN -|-|HYPH 26|26|CD colon|colon|NN carcinoma|carcinoma|NN cells|cell|NNS (|(|-LRB- n|n|NN =|=|SYM 5|5|CD mice|mouse|NNS per|per|IN group|group|NN )|)|-RRB- to|to|TO form|form|VB primary|primary|JJ tumors|tumor|NNS or|or|CC injected|inject|VBN intravenously|intravenously|RB with|with|IN D2F2|d2f2|NN cells|cell|NNS to|to|TO form|form|VB lung|lung|NN metastases|metastase|NNS (|(|-LRB- n|n|NN =|=|SYM 8|8|CD mice|mouse|NNS per|per|IN group|group|NN )|)|-RRB- .|.|. 
All|all|DT animal|animal|NN experiments|experiment|NNS were|be|VBD performed|perform|VBN according|accord|VBG to|to|IN the|the|DT National|National|NNP Institutes|Institutes|NNPS of|of|IN Health|Health|NNP Guide|Guide|NNP for|for|IN Care|Care|NNP and|and|CC Use|Use|NNP of|of|IN Experimental|experimental|JJ Animals|animal|NNS and|and|CC approved|approve|VBN by|by|IN the|the|DT Animal|Animal|NNP Care|Care|NNP Committee|Committee|NNP of|of|IN the|the|DT Burnham|Burnham|NNP Institute|Institute|NNP for|for|IN Medical|Medical|NNP Research|Research|NNP (|(|-LRB- #AUF|#AUF|NNP 04|04|CD -|-|HYPH 152|152|CD )|)|-RRB- .|.|. 
Tumor|tumor|NN -|-|HYPH bearing|bearing|NN mice|mouse|NNS were|be|VBD treated|treat|VBN intravenously|intravenously|RB with|with|IN phosphatebuffered|phosphatebuffer|VBN saline|saline|NN (|(|-LRB- PBS|pbs|NN )|)|-RRB- ,|,|, with|with|IN S.|S.|NNP typhimurium|typhimurium|NN ,|,|, or|or|CC with|with|IN S.|S.|NNP typhimurium|typhimurium|NN containing|contain|VBG control|control|NN (|(|-LRB- empty|empty|JJ )|)|-RRB- plasmid|plasmid|NN or|or|CC FasL|fasl|NN -|-|HYPH encoding|encode|VBG plasmid|plasmid|NN .|.|. 
In|in|IN experiments|experiment|NNS involving|involve|VBG subcutaneous|subcutaneous|JJ tumors|tumor|NNS ,|,|, mice|mouse|NNS were|be|VBD treated|treat|VBN after|after|IN tumors|tumor|NNS reached|reach|VBD a|a|DT size|size|NN that|that|WDT was|be|VBD clearly|clearly|RB visible|visible|JJ ,|,|, whereas|whereas|IN for|for|IN metastatic|metastatic|JJ tumors|tumor|NNS ,|,|, mice|mouse|NNS were|be|VBD treated|treat|VBN at|at|IN 6|6|CD ,|,|, 13|13|CD ,|,|, and|and|CC 20|20|CD days|day|NNS after|after|IN the|the|DT cancer|cancer|NN cells|cell|NNS were|be|VBD injected|inject|VBN .|.|. 
Tumor|tumor|NN volume|volume|NN was|be|VBD assessed|assess|VBN with|with|IN J|J|NNP Natl|Natl|NNP Cancer|Cancer|NNP Inst|Inst|NNP 2008|2008|CD ;|;|: 100:1113|100:1113|CD --|--|: 1116|1116|CD Attenuated|attenuate|VBN Salmonella|salmonella|NN typhimurium|typhimurium|NN have|have|VBP an|a|DT many|many|JJ other|other|JJ potentially|potentially|RB useful|useful|JJ functions|function|NNS have|have|VBP excellent|excellent|JJ safety|safety|NN profile|profile|NN (|(|-LRB- 1,2|1,2|CD )|)|-RRB- ,|,|, a|a|DT propensity|propensity|NN to|to|IN been|be|VBN described|describe|VBN for|for|IN FasL|fasl|NN [|[|-LRB- reviewed|review|VBN in|in|IN (|(|-LRB- 7|7|CD )|)|-RRB- ]|]|-RRB- ,|,|, home|home|NN to|to|IN tumors|tumor|NNS (|(|-LRB- 3|3|CD )|)|-RRB- ,|,|, and|and|CC a|a|DT capacity|capacity|NN to|to|TO syn|syn|VB -|-|: including|include|VBG chemotactic|chemotactic|JJ properties|property|NNS toward|toward|IN thesize|thesize|RB large|large|JJ quantities|quantity|NNS of|of|IN functional|functional|JJ human|human|JJ granulocytes|granulocyte|NNS (|(|-LRB- 8,9|8,9|CD )|)|-RRB- that|that|WDT promote|promote|VBP tumor|tumor|NN rejeccytokines|rejeccytokine|NNS (|(|-LRB- 4|4|CD )|)|-RRB- .|.|. 
Our|we|PRP$ goal|goal|NN was|be|VBD to|to|TO capitalize|capitalize|VB on|on|IN tion|tion|NN (|(|-LRB- 9|9|CD )|)|-RRB- ,|,|, induction|induction|NN of|of|IN IL|il|NN -|-|HYPH 23|23|CD production|production|NN by|by|IN these|these|DT properties|property|NNS as|as|IN a|a|DT strategy|strategy|NN for|for|IN enhancing|enhance|VBG dendritic|dendritic|JJ cells|cell|NNS (|(|-LRB- 10|10|CD )|)|-RRB- ,|,|, and|and|CC stimulation|stimulation|NN of|of|IN CD8|CD8|NNP the|the|DT tumoricidal|tumoricidal|JJ activity|activity|NN of|of|IN this|this|DT strain|strain|NN .|.|. 
In|in|IN this|this|DT T|t|NN -|-|HYPH cell|cell|NN proliferation|proliferation|NN (|(|-LRB- 11|11|CD )|)|-RRB- .|.|. 
However|however|RB ,|,|, systemic|systemic|JJ report|report|NN ,|,|, we|we|PRP performed|perform|VBD a|a|DT preclinical|preclinical|JJ evalua|evalua|NN -|-|HYPH administration|administration|NN of|of|IN recombinant|recombinant|JJ FasL|fasl|NN or|or|CC of|of|IN tion|tion|NN of|of|IN S.|S.|NNP typhimurium|typhimurium|NN bacteria|bacterium|NNS engineered|engineer|VBN agonistic|agonistic|JJ anti-Fas|anti-fas|JJ antibodies|antibody|NNS has|have|VBZ been|be|VBN shown|show|VBN to|to|TO produce|produce|VB the|the|DT cytokine|cytokine|NN Fas|Fas|NNP ligand|ligand|NN (|(|-LRB- FasL|fasl|NN )|)|-RRB- ,|,|, to|to|TO induce|induce|VB lethal|lethal|JJ liver|liver|NN injury|injury|NN (|(|-LRB- 12,13|12,13|CD )|)|-RRB- ,|,|, making|making|NN also|also|RB known|know|VBN as|as|IN CD95L|cd95l|NN /|/|HYPH APO|apo|NN -1|-1|NN L|l|NN ,|,|, using|use|VBG untargeted|untargeted|JJ systemic|systemic|JJ delivery|delivery|NN an|a|DT unacceptable|unacceptable|JJ mouse|mouse|NN tumor|tumor|NN models|model|NNS .|.|. 
Our|we|PRP$ strategy|strategy|NN was|be|VBD to|to|TO strategy|strategy|NN .|.|. 
Here|here|RB ,|,|, we|we|PRP used|use|VBD FasL|fasl|NN as|as|IN a|a|DT test|test|NN case|case|NN for|for|IN engineer|engineer|NN attenuated|attenuate|VBN S.|S.|NNP typhimurium|typhimurium|NN to|to|TO pro-|pro-_VB|VB investigating|investigate|VBG the|the|DT feasibility|feasibility|NN of|of|IN using|use|VBG attenu|attenu|NN -|-|HYPH duce|duce|NN cytokines|cytokine|NNS that|that|WDT have|have|VBP known|know|VBN antitumor|antitumor|JJ ated|ate|VBN S.|S.|NNP typhimurium|typhimurium|NN as|as|IN a|a|DT tumor|tumor|NN -|-|HYPH speciﬁc|speciﬁc|NN transactivity|transactivity|NN but|but|CC that|that|DT are|be|VBP too|too|RB toxic|toxic|JJ to|to|TO use|use|VB sys|sy|NNS -|-|HYPH porter|porter|NN for|for|IN cytotoxic|cytotoxic|JJ and|and|CC immunostimulatory|immunostimulatory|JJ temically|temically|RB without|without|IN targeting|target|VBG .|.|. 
therapeutic|therapeutic|JJ proteins|proteins|NN .|.|. 
FasL|fasl|NN is|be|VBZ a|a|DT membrane|membrane|NN protein|protein|NN that|that|WDT belongs|belong|VBZ To|to|IN engineer|engineer|NN the|the|DT attenuated|attenuate|VBN S.|S.|NNP typhito|typhito|NNP the|the|DT tumor|tumor|NN necrosis|necrosis|NN factor|factor|NN family|family|NN of|of|IN pro-|pro-_VB|VB murium|murium|NN strain|strain|NN purI0|puri0|NN -|-|SYM /|/|HYPH msbB|msbb|NN -|-|HYPH (|(|-LRB- 14|14|CD )|)|-RRB- to|to|TO express|express|VB teins|tein|NNS .|.|. 
After|after|IN binding|bind|VBG to|to|IN its|its|PRP$ receptor|receptor|NN (|(|-LRB- Fas|Fas|NNP )|)|-RRB- ,|,|, it|it|PRP FasL|fasl|NN ,|,|, we|we|PRP transformed|transform|VBD these|these|DT bacteria|bacterium|NNS with|with|IN initiates|initiate|VBZ an|a|DT apoptotic|apoptotic|JJ signal|signal|NN in|in|IN Fas|Fas|NNP -|-|HYPH sensitive|sensitive|JJ the|the|DT plasmid|plasmid|NN pGEN206|pgen206|NN ,|,|, from|from|IN which|which|WDT a|a|DT fusion|fusion|NN cells|cell|NNS (|(|-LRB- 5|5|CD )|)|-RRB- .|.|. 
This|this|DT mechanism|mechanism|NN is|be|VBZ of|of|IN particular|particular|JJ of|of|IN the|the|DT extracellular|extracellular|JJ domains|domain|NNS of|of|IN human|human|JJ CD8|cd8|NN importance|importance|NN for|for|IN a|a|DT variety|variety|NN of|of|IN physiological|physiological|JJ and|and|CC and|and|CC murine|murine|JJ FasL|fasl|NN [|[|-LRB- FasL|fasl|NN --|--|: CD8|cd8|NN ,|,|, a|a|DT gift|gift|NN from|from|IN pathological|pathological|JJ conditions|condition|NNS ,|,|, including|include|VBG the|the|DT killing|kill|VBG Dr|Dr|NNP H.|H.|NNP Yigaki|Yigaki|NNP (|(|-LRB- 15|15|CD )|)|-RRB- ]|]|-RRB- with|with|IN an|a|DT appended|append|VBN N|n|NN -|-|HYPH of|of|IN transformed|transform|VBN target|target|NN cells|cell|NNS by|by|IN cytotoxic|cytotoxic|JJ T|t|NN terminal|terminal|JJ leader|leader|NN sequence|sequence|NN that|that|WDT directs|direct|VBZ prolymphocytes|prolymphocyte|NNS and|and|CC natural|natural|JJ killer|killer|NN cells|cell|NNS (|(|-LRB- 6|6|CD )|)|-RRB- .|.|. 
In|in|IN tein|tein|NN secretion|secretion|NN [|[|-LRB- MISSSSIS|missssis|NN (|(|-LRB- 16|16|CD )|)|-RRB- ]|]|-RRB- was|be|VBD expressed|express|VBN addition|addition|NN to|to|IN its|its|PRP$ proapoptotic|proapoptotic|JJ activity|activity|NN ,|,|, however|however|RB ,|,|, under|under|IN the|the|DT control|control|NN of|of|IN an|a|DT ompC|ompc|NN promoter|promoter|NN .|.|. 
Affiliation|Affiliation|NNP of|of|IN authors|author|NNS :|:|: Burnham|Burnham|NNP Institute|Institute|NNP for|for|IN Medical|Medical|NNP Research|Research|NNP ,|,|, La|La|NNP Jolla|Jolla|NNP ,|,|, CA|CA|NNP .|.|. 
Correspondence|correspondence|NN to|to|TO :|:|: John|John|NNP C.|C.|NNP Reed|Reed|NNP ,|,|, MD|MD|NNP ,|,|, PhD|phd|NN ,|,|, Burnham|Burnham|NNP Institute|Institute|NNP for|for|IN Medical|Medical|NNP Research|Research|NNP ,|,|, 10901|10901|CD North|north|JJ Torrey|Torrey|NNP Pines|pine|NNS Rd|rd|NN ,|,|, La|La|NNP Jolla|Jolla|NNP ,|,|, CA|CA|NNP 92037|92037|CD (|(|-LRB- e-mail|e-mail|NN :|:|: reedoffice@burnham.org|reedoffice@burnham.org|ADD )|)|-RRB- .|.|. 
See|see|VB ``|``|`` Funding|fund|VBG ''|''|'' and|and|CC ``|``|`` Notes|Notes|NNPS ''|''|'' following|follow|VBG ``|``|`` References|reference|NNS .|.|. ''|''|'' 
DOI|doi|NN :|:|: 10.1093|10.1093|CD /|/|SYM jnci|jnci|NN /|/|SYM djn205|djn205|NN ©|©|SYM 2008|2008|CD The|the|DT Author|author|NN (|(|-LRB- s|s|AFX )|)|-RRB- .|.|. 
This|this|DT is|be|VBZ an|a|DT Open|Open|NNP Access|Access|NNP article|article|NN distributed|distribute|VBN under|under|IN the|the|DT terms|term|NNS of|of|IN the|the|DT Creative|Creative|NNP Commons|Commons|NNP Attribution|Attribution|NNP Non-Commercial|non-commercial|JJ License|license|NN (|(|-LRB- http://creativecommons|http://creativecommons|ADD .|.|. 
org|org|NN /|/|HYPH licenses|licens|NNS /|/|HYPH by|by|IN -|-|HYPH nc|nc|NN /|/|HYPH 2.0|2.0|CD /|/|HYPH uk|uk|NNP /|/|SYM )|)|-RRB- ,|,|, which|which|WDT permits|permit|VBZ unrestricted|unrestricted|JJ non-commercial|non-commercial|JJ use|use|NN ,|,|, distribution|distribution|NN ,|,|, and|and|CC reproduction|reproduction|NN in|in|IN any|any|DT medium|medium|NN ,|,|, provided|provide|VBD the|the|DT original|original|JJ work|work|NN is|be|VBZ properly|properly|RB cited|cite|VBN .|.|. 
Prior|prior|JJ knowledge|knowledge|NN Salmonella|salmonella|NN typhimurium|typhimurium|NN ,|,|, a|a|DT facultative|facultative|NN an|a|DT -|-|HYPH aerobe|aerobe|NN ,|,|, has|have|VBZ been|be|VBN shown|show|VBN to|to|TO accumulate|accumulate|VB at|at|IN tumor|tumor|NN sites|site|NNS when|when|WRB injected|inject|VBN intravenously|intravenously|RB into|into|IN mouse|mouse|NN tumor|tumor|NN models|model|NNS .|.|. 
Intravenous|intravenous|JJ injection|injection|NN of|of|IN attenuated|attenuate|VBN strains|strain|NNS has|have|VBZ been|be|VBN well|well|RB tolerated|tolerate|VBN .|.|. 
Study|study|NN design|design|NN Attenuated|attenuate|VBN S.|S.|NNP typhimurium|typhimurium|NN were|be|VBD engineered|engineer|VBN to|to|TO express|express|VB Fas|Fas|NNP ligand|ligand|NN (|(|-LRB- FasL|fasl|NN )|)|-RRB- to|to|TO deliver|deliver|VB this|this|DT toxic|toxic|JJ ,|,|, antitumor|antitumor|JJ cytokine|cytokine|NN to|to|IN tumor|tumor|NN sites|site|NNS and|and|CC to|to|TO thereby|thereby|RB enhance|enhance|VB therapeutic|therapeutic|JJ potential|potential|NN .|.|. 
Contribution|contribution|NN S.|S.|NNP typhimurium|typhimurium|NN expressing|express|VBG FasL|fasl|NN dramatically|dramatically|RB inhibited|inhibit|VBD the|the|DT growth|growth|NN of|of|IN D2F2|d2f2|NN murine|murine|JJ breast|breast|NN carcinoma|carcinoma|NN and|and|CC CT|ct|NN -|-|HYPH 26|26|CD murine|murine|JJ colon|colon|NN carcinoma|carcinoma|NN tumors|tumor|NNS ,|,|, as|as|RB well|well|RB as|as|IN the|the|DT growth|growth|NN of|of|IN D2F2|d2f2|NN pulmonary|pulmonary|JJ metastases|metastase|NNS in|in|IN mice|mouse|NNS .|.|. 
Implications|implication|NNS S.|S.|NNP typhimurium|typhimurium|NN expressing|express|VBG FasL|fasl|NN may|may|MD hold|hold|VB promise|promise|NN for|for|IN the|the|DT treatment|treatment|NN of|of|IN some|some|DT human|human|JJ tumors|tumor|NNS .|.|. 
Limitations|Limitations|NNPS These|these|DT experiments|experiment|NNS involved|involve|VBN murine|murine|JJ tumor|tumor|NN models|model|NNS ,|,|, and|and|CC the|the|DT effects|effect|NNS of|of|IN FasL|fasl|NN -|-|HYPH expressing|express|VBG S.|S.|NNP typhimurium|typhimurium|NN on|on|IN human|human|JJ tumor|tumor|NN models|model|NNS are|be|VBP not|not|RB yet|yet|RB known|know|VBN .|.|. 
calipers|caliper|NNS every|every|DT 4|4|CD days|day|NNS from|from|IN days|day|NNS 14|14|CD to|to|IN 46|46|CD for|for|IN D2F2|d2f2|NN breast|breast|NN tumors|tumor|NNS (|(|-LRB- Figure|figure|NN 1|1|CD ,|,|, B|b|NN )|)|-RRB- and|and|CC on|on|IN days|day|NNS 11|11|CD ,|,|, 16|16|CD ,|,|, 21|21|CD ,|,|, and|and|CC 25|25|CD for|for|IN CT|ct|NN -|-|HYPH 26|26|CD colon|colon|NN tumors|tumor|NNS (|(|-LRB- Figure|figure|NN 1|1|CD ,|,|, C|c|NN )|)|-RRB- .|.|. 
In|in|IN mice|mouse|NNS treated|treat|VBN with|with|IN S.|S.|NNP typhimurium|typhimurium|NN containing|contain|VBG the|the|DT FasL|fasl|NN expression|expression|NN vector|vector|NN ,|,|, tumor|tumor|NN growth|growth|NN was|be|VBD statistically|statistically|RB signiﬁcantly|signiﬁcantly|RB reduced|reduce|VBN compared|compare|VBN with|with|IN that|that|DT in|in|IN control|control|NN groups|group|NNS .|.|. 
For|for|IN example|example|NN ,|,|, after|after|IN 46|46|CD days|day|NNS of|of|IN treatment|treatment|NN ,|,|, mean|mean|VB D2F2|d2f2|NN tumor|tumor|NN volumes|volume|NNS were|be|VBD 827|827|CD ,|,|, 847|847|CD ,|,|, 949|949|CD ,|,|, 3|3|CD and|and|CC 336|336|CD mm|mm|NN for|for|IN the|the|DT groups|group|NNS treated|treat|VBN with|with|IN PBS|pbs|NN ,|,|, S.|S.|NNP typhimurium|typhimurium|NN ,|,|, S.|S.|NNP typhimurium|typhimurium|NN --|--|: vector|vector|NN ,|,|, and|and|CC S.|S.|NNP typhimurium|typhimurium|NN --|--|: FasL|fasl|NN ,|,|, respectively|respectively|RB (|(|-LRB- for|for|IN PBS|pbs|NN -|-|HYPH vs|vs|IN FasL|fasl|NN -|-|HYPH treated|treat|VBN D2F2|d2f2|NN tumors|tumor|NNS ,|,|, difference|difference|NN =|=|SYM 491|491|CD mm3|mm3|NN ,|,|, 95|95|CD %|%|NN conﬁdence|conﬁdence|NN interval|interval|NN [|[|-LRB- CI|ci|NN ]|]|-RRB- =|=|SYM 34|34|CD to|to|IN 984|984|CD ,|,|, P|p|NN =|=|SYM .02|.02|CD )|)|-RRB- (|(|-LRB- Figure|figure|NN 1|1|CD ,|,|, B|b|NN )|)|-RRB- .|.|. 
At|at|IN 25|25|CD days|day|NNS after|after|IN initial|initial|JJ treatment|treatment|NN ,|,|, mean|mean|VB CT|ct|NN -|-|HYPH 26|26|CD tumor|tumor|NN volumes|volume|NNS were|be|VBD 1385|1385|CD mm3|mm3|NN and|and|CC 243|243|CD mm3|mm3|NN for|for|IN the|the|DT groups|group|NNS treated|treat|VBN with|with|IN PBS|pbs|NN vs|vs|IN S.|S.|NNP typhimurium|typhimurium|NN --|--|: FasL|fasl|NN ,|,|, respectively|respectively|RB (|(|-LRB- difference|difference|NN =|=|SYM 1142|1142|CD mm3|mm3|NN ,|,|, 95|95|CD %|%|NN CI|ci|NN =|=|SYM 800|800|CD to|to|IN 1484|1484|CD ,|,|, P|p|NN <|<|SYM .001|.001|CD )|)|-RRB- (|(|-LRB- Figure|figure|NN 1|1|CD ,|,|, C|c|NN )|)|-RRB- .|.|. 
We|we|PRP also|also|RB observed|observe|VBD that|that|IN mice|mouse|NNS treated|treat|VBN with|with|IN FasL|fasl|NN -|-|HYPH expressing|express|VBG S.|S.|NNP typh|typh|NN -|-|HYPH imurium|imurium|NN showed|show|VBD a|a|DT 34|34|CD %|%|NN reduction|reduction|NN in|in|IN the|the|DT which|which|WDT neutrophils|neutrophil|NNS were|be|VBD not|not|RB depleted|deplete|VBN =|=|SYM 679|679|CD mg|mg|NNS ,|,|, difference|difference|NN =|=|SYM 726|726|CD mg|mg|NNS ,|,|, 95|95|CD %|%|NN CI|ci|NN =|=|SYM 355|355|CD to|to|IN 1097|1097|CD mg|mg|NNS ,|,|, P|p|NN =|=|SYM .001|.001|CD )|)|-RRB- .|.|. 
Although|although|IN demonstrating|demonstrate|VBG antitumor|antitumor|JJ activity|activity|NN ,|,|, FasL|fasl|NN -|-|HYPH expressing|express|VBG S.|S.|NNP typhimurium|typhimurium|NN did|do|VBD not|not|RB cause|cause|VB greater|greater|JJR systemic|systemic|JJ toxicity|toxicity|NN than|than|IN the|the|DT unmodiﬁed|unmodiﬁed|JJ attenuated|attenuate|VBN S.|S.|NNP typhimurium|typhimurium|NN strain|strain|NN .|.|. 
Histological|histological|JJ analysis|analysis|NN of|of|IN multiple|multiple|JJ organs|organ|NNS (|(|-LRB- lungs|lung|NNS ,|,|, kidneys|kidney|NNS ,|,|, spleens|spleen|NNS ,|,|, and|and|CC heart|heart|NN )|)|-RRB- showed|show|VBD minimal|minimal|JJ changes|change|NNS (|(|-LRB- data|datum|NNS not|not|RB shown|show|VBN )|)|-RRB- that|that|WDT were|be|VBD comparable|comparable|JJ to|to|IN the|the|DT results|result|NNS obtained|obtain|VBN previously|previously|RB with|with|IN control|control|NN S.|S.|NNP typhimurium|typhimurium|NN that|that|WDT did|do|VBD not|not|RB produce|produce|VB FasL|fasl|NN (|(|-LRB- 7|7|CD --|--|, 10|10|CD )|)|-RRB- .|.|. 
Thus|thus|RB ,|,|, addition|addition|NN of|of|IN FasL|fasl|NN did|do|VBD not|not|RB worsen|worsen|VB the|the|DT toxicity|toxicity|NN observed|observe|VBN with|with|IN S.|S.|NNP typhimurium|typhimurium|NN ,|,|, which|which|WDT has|have|VBZ been|be|VBN shown|show|VBN previously|previously|RB to|to|TO be|be|VB well|well|RB tolerated|tolerate|VBN in|in|IN humans|human|NNS (|(|-LRB- 1,4|1,4|CD )|)|-RRB- .|.|. 
Here|here|RB ,|,|, we|we|PRP have|have|VBP demonstrated|demonstrate|VBN that|that|IN systemic|systemic|JJ delivery|delivery|NN of|of|IN attenuated|attenuate|VBN S.|S.|NNP typhimurium|typhimurium|NN expressing|express|VBG a|a|DT soluble|soluble|JJ version|version|NN of|of|IN FasL|fasl|NN reduces|reduce|VBZ growth|growth|NN of|of|IN primary|primary|JJ tumors|tumor|NNS and|and|CC pulmonary|pulmonary|JJ metastases|metastase|NNS in|in|IN mouse|mouse|NN cancer|cancer|NN models|model|NNS (|(|-LRB- 21|21|CD )|)|-RRB- using|use|VBG multidrug|multidrug|JJ -|-|HYPH resistant|resistant|JJ murine|murine|JJ tumors|tumor|NNS in|in|IN immunocompetent|immunocompetent|NN animals|animal|NNS .|.|. 
In|in|IN mice|mouse|NNS depleted|deplete|VBN in|in|FW vivo|vivo|FW of|of|IN neutro|neutro|NN -|-|HYPH phils|phil|NNS ,|,|, the|the|DT antitumor|antitumor|JJ effect|effect|NN of|of|IN treatment|treatment|NN with|with|IN FasL|fasl|NN -|-|HYPH expressing|express|VBG bacteria|bacterium|NNS was|be|VBD severely|severely|RB impaired|impair|VBN ,|,|, corroborating|corroborate|VBG ﬁndings|ﬁndings|NNS from|from|IN previous|previous|JJ studies|study|NNS in|in|IN which|which|WDT FasL|fasl|NN was|be|VBD applied|apply|VBN intratumorally|intratumorally|RB (|(|-LRB- 9|9|CD )|)|-RRB- .|.|. 
Moreover|moreover|RB ,|,|, Fas|Fas|NNP expression|expression|NN on|on|IN host|host|NN rather|rather|RB than|than|IN tumor|tumor|NN cells|cell|NNS was|be|VBD found|find|VBN to|to|TO be|be|VB critical|critical|JJ for|for|IN antitumor|antitumor|JJ activity|activity|NN ,|,|, based|base|VBN on|on|IN experiments|experiment|NNS using|use|VBG lpr|lpr|NN /|/|HYPH lpr|lpr|NN mice|mouse|NNS ,|,|, which|which|WDT lack|lack|VBP the|the|DT receptor|receptor|NN for|for|IN FasL|fasl|NN .|.|. 
Thus|thus|RB ,|,|, the|the|DT observed|observe|VBN antitumor|antitumor|JJ effects|effect|NNS of|of|IN FasL|fasl|NN -|-|HYPH expressing|express|VBG S.|S.|NNP typhimurium|typhimurium|NN appear|appear|VBP to|to|TO rely|rely|VB largely|largely|RB on|on|IN a|a|DT host|host|NN inﬂammatory|inﬂammatory|JJ reaction|reaction|NN to|to|IN the|the|DT tumor|tumor|NN ,|,|, rather|rather|RB than|than|IN on|on|IN a|a|DT direct|direct|JJ pro-apoptotic|pro-apoptotic|JJ effect|effect|NN on|on|IN tumor|tumor|NN cells|cell|NNS .|.|. 
Unlike|unlike|IN systemically|systemically|RB delivered|deliver|VBN agonistic|agonistic|JJ anti-Fas|anti-fas|JJ antibodies|antibody|NNS or|or|CC FasL|fasl|NN ,|,|, which|which|WDT have|have|VBP toxic|toxic|JJ effects|effect|NNS ,|,|, mice|mouse|NNS appeared|appear|VBD to|to|TO tolerate|tolerate|VB FasL|fasl|NN -|-|HYPH expressing|express|VBG bacterial|bacterial|JJ therapy|therapy|NN well|well|RB ;|;|: however|however|RB ,|,|, formal|formal|JJ preclinical|preclinical|JJ toxicology|toxicology|NN studiesshouldbeperformed.Histopathologic|studiesshouldbeperformed.histopathologic|NN analyses|analysis|NNS of|of|IN various|various|JJ organs|organ|NNS showed|show|VBD only|only|RB modest|modest|JJ changes|change|NNS that|that|WDT were|be|VBD similar|similar|JJ in|in|IN extent|extent|NN for|for|IN control|control|NN and|and|CC FasL|fasl|NN -|-|HYPH expressing|express|VBG S.|S.|NNP typhimurium|typhimurium|NN ,|,|, thus|thus|RB conﬁrming|conﬁrming|VBG previous|previous|JJ reports|report|NNS (|(|-LRB- 2,19|2,19|CD )|)|-RRB- .|.|. 
Together|together|RB with|with|IN other|other|JJ preclinical|preclinical|JJ (|(|-LRB- 1,19|1,19|CD )|)|-RRB- and|and|CC clinical|clinical|JJ (|(|-LRB- 22|22|CD )|)|-RRB- studies|study|NNS that|that|WDT have|have|VBP documented|document|VBN minimal|minimal|JJ side|side|NN effects|effect|NNS of|of|IN CONTEXT|CONTEXT|NNP AND|and|CC CAVEATS|CAVEATS|NNP Figure|figure|NN 1|1|CD .|.|. 
Inhibition|inhibition|NN of|of|IN tumor|tumor|NN growth|growth|NN using|use|VBG Fas|Fas|NNP ligand|ligand|NN (|(|-LRB- FasL|fasl|NN )|)|-RRB- --|--|: expressing|express|VBG Salmonella|Salmonella|NNP typhimurium|typhimurium|NN .|.|. 
A|a|NN )|)|-RRB- FasL|fasl|NN expression|expression|NN and|and|CC secretion|secretion|NN .|.|. 
FasL|fasl|NN protein|protein|NN expression|expression|NN was|be|VBD veriﬁed|veriﬁed|VBN by|by|IN immunoblot|immunoblot|NN analysis|analysis|NN of|of|IN cell|cell|NN lysates|lysate|NNS (|(|-LRB- pellet|pellet|NN )|)|-RRB- or|or|CC culture|culture|NN supernatants|supernatant|NNS (|(|-LRB- sup|sup|NN )|)|-RRB- from|from|IN S.|S.|NNP typhimurium|typhimurium|NN containing|contain|VBG empty|empty|JJ vector|vector|NN (|(|-LRB- Sal|Sal|NNP )|)|-RRB- or|or|CC FasL|fasl|NN -|-|HYPH expressing|express|VBG plasmid|plasmid|NN --|--|: transformed|transform|VBN S.|S.|NNP typhimurium|typhimurium|NN (|(|-LRB- Sal|Sal|NNP +|+|SYM FasL|FasL|NNP )|)|-RRB- .|.|. 
Immunoblots|immunoblot|NNS were|be|VBD performed|perform|VBN as|as|IN described|describe|VBN previously|previously|RB (|(|-LRB- 14|14|CD )|)|-RRB- .|.|. 
Samples|sample|NNS were|be|VBD normalized|normalize|VBN for|for|IN total|total|JJ protein|protein|NN content|content|NN .|.|. 
Blots|blot|NNS were|be|VBD probed|probe|VBN with|with|IN rat|rat|NN monoclonal|monoclonal|JJ anti-mouse|anti-mouse|JJ FasL|fasl|NN antibody|antibody|NN (|(|-LRB- Alexis|Alexis|NNP ,|,|, San|San|NNP Diego|Diego|NNP ,|,|, CA|CA|NNP )|)|-RRB- at|at|IN 1:500|1:500|CD dilution|dilution|NN .|.|. 
Protein|protein|NN --|--|: antibody|antibody|NN complexes|complex|NNS were|be|VBD visualized|visualize|VBN by|by|IN an|a|DT enhanced|enhance|VBN chemiluminescence|chemiluminescence|NN (|(|-LRB- ECL|ecl|NN )|)|-RRB- method|method|NN (|(|-LRB- Amersham|Amersham|NNP )|)|-RRB- .|.|. 
Results|result|NNS are|be|VBP representative|representative|JJ of|of|IN three|three|CD independent|independent|JJ experiments|experiment|NNS .|.|. 
B|b|NN )|)|-RRB- Effect|effect|NN on|on|IN D2F2|d2f2|NN tumor|tumor|NN growth|growth|NN .|.|. 
BALB|balb|NN /|/|HYPH c|c|NN mice|mouse|NNS (|(|-LRB- n|n|NN =|=|SYM 8|8|CD per|per|IN group|group|NN )|)|-RRB- were|be|VBD subject|subject|JJ to|to|IN subcutaneous|subcutaneous|JJ injection|injection|NN with|with|IN 1.5|1.5|CD ×|×|SYM 105|105|CD D2F2|d2f2|NN breast|breast|NN carcinoma|carcinoma|NN cells|cell|NNS suspended|suspend|VBN in|in|IN 100|100|CD µL|µl|NN of|of|IN phosphate|phosphate|NN -|-|HYPH buffered|buffer|VBN saline|saline|NN (|(|-LRB- PBS|pbs|NN )|)|-RRB- followed|follow|VBD after|after|IN 14|14|CD days|day|NNS by|by|IN intravenous|intravenous|JJ treatment|treatment|NN with|with|IN PBS|pbs|NN (|(|-LRB- closed|close|VBN diamonds|diamond|NNS )|)|-RRB- ,|,|, S.|S.|NNP typhimurium|typhimurium|NN (|(|-LRB- closed|closed|JJ squares|square|NNS )|)|-RRB- ,|,|, S.|S.|NNP typhimurium|typhimurium|NN with|with|IN empty|empty|JJ vector|vector|NN (|(|-LRB- closed|close|VBN triangles|triangle|NNS )|)|-RRB- ,|,|, or|or|CC S.|S.|NNP typhimurium|typhimurium|NN with|with|IN FasL|fasl|NN vector|vector|NN (|(|-LRB- open|open|JJ circles|circle|NNS )|)|-RRB- .|.|. 
All|all|DT bacterial|bacterial|JJ doses|dose|NNS were|be|VBD 5|5|CD ×|×|SYM 106|106|CD colony|colony|NN -|-|HYPH forming|form|VBG units|unit|NNS per|per|IN mouse|mouse|NN suspended|suspend|VBN in|in|IN 100|100|CD µL|µl|NN of|of|IN PBS|pbs|NN ,|,|, a|a|DT dose|dose|NN selected|select|VBN based|base|VBN on|on|IN prior|prior|JJ preclinical|preclinical|JJ and|and|CC clinical|clinical|JJ studies|study|NNS and|and|CC that|that|DT is|be|VBZ known|know|VBN to|to|TO be|be|VB nontoxic|nontoxic|JJ or|or|CC minimally|minimally|RB toxic|toxic|JJ (|(|-LRB- 1,3,16|1,3,16|CD )|)|-RRB- .|.|. 
All|all|DT graphs|graph|NNS indicate|indicate|VBP average|average|JJ tumor|tumor|NN volumes|volume|NNS as|as|IN estimated|estimate|VBN by|by|IN external|external|JJ calipers|caliper|NNS (|(|-LRB- means|means|NNS with|with|IN 95|95|CD %|%|NN conﬁdence|conﬁdence|NN intervals|interval|NNS [|[|-LRB- CIs|cis|NN ]|]|-RRB- )|)|-RRB- (|(|-LRB- 14|14|CD )|)|-RRB- .|.|. 
Results|result|NNS are|be|VBP representative|representative|JJ of|of|IN four|four|CD independent|independent|JJ experiments|experiment|NNS .|.|. 
C|c|NN )|)|-RRB- Effect|effect|NN on|on|IN CT|ct|NN -|-|HYPH 26|26|CD tumor|tumor|NN growth|growth|NN .|.|. 
BALB|balb|NN /|/|HYPH c|c|NN mice|mouse|NNS (|(|-LRB- n|n|NN =|=|SYM 5|5|CD per|per|IN group|group|NN )|)|-RRB- were|be|VBD injected|inject|VBN subcutaneously|subcutaneously|RB with|with|IN 2.5|2.5|CD ×|×|SYM 105|105|CD CT|ct|NN -|-|HYPH 26|26|CD colon|colon|NN carcinoma|carcinoma|NN cells|cell|NNS followed|follow|VBD 9|9|CD ,|,|, 14|14|CD ,|,|, and|and|CC 19|19|CD days|day|NNS later|later|RB by|by|IN intravenous|intravenous|JJ treatment|treatment|NN with|with|IN PBS|pbs|NN (|(|-LRB- closed|close|VBN diamonds|diamond|NNS )|)|-RRB- or|or|CC S.|S.|NNP typhimurium|typhimurium|NN with|with|IN FasL|fasl|NN vector|vector|NN (|(|-LRB- open|open|JJ circles|circle|NNS )|)|-RRB- .|.|. 
Graphs|graph|NNS indicate|indicate|VBP average|average|JJ tumor|tumor|NN volumes|volume|NNS from|from|IN the|the|DT time|time|NN that|that|WDT tumor|tumor|NN challenge|challenge|NN was|be|VBD initiated|initiate|VBN (|(|-LRB- means|means|NNS with|with|IN 95|95|CD %|%|NN CIs|cis|NN )|)|-RRB- .|.|. 
Results|result|NNS are|be|VBP representative|representative|JJ of|of|IN four|four|CD independent|independent|JJ experiments|experiment|NNS .|.|. 
D|d|LS )|)|-RRB- and|and|CC E|e|NN )|)|-RRB- Effect|effect|NN on|on|IN D2F2|d2f2|NN metastasis|metastasis|NN .|.|. 
BALB|balb|NN /|/|HYPH c|c|NN mice|mouse|NNS (|(|-LRB- n|n|NN =|=|SYM 8|8|CD per|per|IN group|group|NN )|)|-RRB- were|be|VBD injected|inject|VBN intravenously|intravenously|RB with|with|IN 7.5|7.5|CD ×|×|SYM 104|104|CD D2F2|d2f2|NN breast|breast|NN carcinoma|carcinoma|NN cells|cell|NNS followed|follow|VBD 6|6|CD ,|,|, 13|13|CD ,|,|, and|and|CC 20|20|CD days|day|NNS later|later|RB by|by|IN intravenous|intravenous|JJ treatment|treatment|NN with|with|IN PBS|pbs|NN ,|,|, S.|S.|NNP typhimurium|typhimurium|NN (|(|-LRB- Sal|Sal|NNP )|)|-RRB- ,|,|, S.|S.|NNP typhimurium|typhimurium|NN containing|contain|VBG empty|empty|JJ vector|vector|NN (|(|-LRB- Sal|Sal|NNP +|+|SYM vector|vector|NN )|)|-RRB- ,|,|, or|or|CC S.|S.|NNP typhimurium|typhimurium|NN containing|contain|VBG the|the|DT FasL|fasl|NN plasmid|plasmid|NN (|(|-LRB- Sal|Sal|NNP +|+|SYM FasL|FasL|NNP )|)|-RRB- .|.|. 
Mice|mouse|NNS were|be|VBD killed|kill|VBN after|after|IN 41|41|CD days|day|NNS with|with|IN an|a|DT overdose|overdose|NN of|of|IN intraperitoneal|intraperitoneal|JJ Avertin|avertin|NN anesthetic|anesthetic|NN (|(|-LRB- 0.017|0.017|CD mL|ml|NN /|/|SYM g|g|NN body|body|NN weight|weight|NN ;|;|: Aldrich|Aldrich|NNP ,|,|, Milwaukee|Milwaukee|NNP ,|,|, WI|WI|NNP )|)|-RRB- followed|follow|VBN by|by|IN cervical|cervical|JJ dislocation|dislocation|NN .|.|. 
and|and|CC lungs|lung|NNS were|be|VBD weighed|weigh|VBN (|(|-LRB- D|d|NN )|)|-RRB- and|and|CC examined|examine|VBN for|for|IN metastases|metastase|NNS (|(|-LRB- E|e|NN )|)|-RRB- .|.|. 
The|the|DT fraction|fraction|NN of|of|IN lung|lung|NN surface|surface|NN covered|cover|VBN by|by|IN fused|fuse|VBN metastases|metastase|NNS was|be|VBD scored|score|VBN as|as|IN follows|follow|VBZ :|:|: 0|0|CD =|=|SYM 0|0|CD %|%|NN ,|,|, 1|1|CD =|=|SYM less|less|JJR than|than|IN 20|20|CD %|%|NN ,|,|, 2|2|CD =|=|SYM 20|20|CD %|%|NN --|--|: 50|50|CD %|%|NN ,|,|, 3|3|CD =|=|SYM more|more|JJR than|than|IN 50|50|CD %|%|NN .|.|. 
Values|value|NNS are|be|VBP means|means|NNS with|with|IN 95|95|CD %|%|NN CIs|ci|NNS .|.|. 
*|*|NFP P|p|NN <|<|SYM .05|.05|CD .|.|. 
Results|result|NNS are|be|VBP representative|representative|JJ of|of|IN four|four|CD independent|independent|JJ experiments|experiment|NNS .|.|. 
D2F2|d2f2|NN cells|cell|NNS were|be|VBD a|a|DT gift|gift|NN from|from|IN Dr|Dr|NNP Wei|Wei|NNP -|-|HYPH Zen|Zen|NNP Wei|Wei|NNP (|(|-LRB- Karmanos|Karmanos|NNP Cancer|Cancer|NNP Institute|Institute|NNP ,|,|, Detroit|Detroit|NNP ,|,|, MI|MI|NNP )|)|-RRB- and|and|CC CT|ct|NN -|-|HYPH 26|26|CD cells|cell|NNS were|be|VBD obtained|obtain|VBN from|from|IN ATCC|atcc|NN (|(|-LRB- Manassas|Manassas|NNP ,|,|, VA|VA|NNP )|)|-RRB- .|.|. 
Female|female|JJ BALB|balb|NN /|/|HYPH c|c|NN mice|mouse|NNS at|at|IN 6|6|CD --|--|: 8|8|CD weeks|week|NNS of|of|IN age|age|NN were|be|VBD purchased|purchase|VBN from|from|IN The|the|DT Jackson|Jackson|NNP Laboratory|Laboratory|NNP (|(|-LRB- Bar|Bar|NNP Harbor|Harbor|NNP ,|,|, ME|ME|NNP )|)|-RRB- .|.|. 
Two|two|CD -|-|HYPH tailed|tail|VBN Student|student|NN t|t|NN tests|test|NNS were|be|VBD used|use|VBN to|to|TO determine|determine|VB the|the|DT statistical|statistical|JJ signiﬁcance|signiﬁcance|NN of|of|IN primary|primary|JJ tumor|tumor|NN growth|growth|NN differences|difference|NNS between|between|IN control|control|NN and|and|CC treatment|treatment|NN groups|group|NNS .|.|. 
In|in|IN the|the|DT case|case|NN of|of|IN metastasis|metastasis|NN scores|score|NNS ,|,|, statistical|statistical|JJ signiﬁcance|signiﬁcance|NN was|be|VBD determined|determine|VBN by|by|IN Mann|Mann|NNP --|--|: Whitney|Whitney|NNP U|U|NNP tests|test|NNS .|.|. 
P|p|NN values|value|NNS of|of|IN .05|.05|CD or|or|CC less|less|JJR were|be|VBD deemed|deem|VBN statistically|statistically|RB signiﬁcant|signiﬁcant|JJ .|.|. 
From|from|IN the|the|DT Editors|editor|NNS growth|growth|NN of|of|IN D2F2|d2f2|NN experimental|experimental|JJ metastases|metastase|NNS (|(|-LRB- as|as|IN measured|measure|VBN by|by|IN lung|lung|NN weight|weight|NN )|)|-RRB- compared|compare|VBN with|with|IN PBS|pbs|NN -|-|HYPH treated|treat|VBN control|control|NN mice|mouse|NNS ,|,|, with|with|IN lung|lung|NN weights|weight|NNS remaining|remain|VBG almost|almost|RB normal|normal|JJ compared|compare|VBN with|with|IN mice|mouse|NNS receiving|receive|VBG other|other|JJ treatments|treatment|NNS (|(|-LRB- measured|measure|VBN at|at|IN 41|41|CD days|day|NNS ,|,|, mean|mean|VB lung|lung|NN weights|weight|NNS were|be|VBD 0.29|0.29|CD g|g|NN ,|,|, 0.27|0.27|CD g|g|NN ,|,|, 0.34|0.34|CD g|g|NN ,|,|, and|and|CC 0.19|0.19|CD g|g|NN for|for|IN the|the|DT PBS|pbs|NN ,|,|, S.|S.|NNP typhimurium|typhimurium|NN ,|,|, S.|S.|NNP typhimurium|typhimurium|NN --|--|: vector|vector|NN ,|,|, and|and|CC S.|S.|NNP typhimurium|typhimurium|NN --|--|: FasL|fasl|NN groups|group|NNS ,|,|, respectively|respectively|RB ;|;|: for|for|IN PBS|pbs|NN -|-|HYPH vs|vs|IN FasL|fasl|NN -|-|HYPH treated|treat|VBN D2F2|d2f2|NN metastases|metastase|NNS ,|,|, difference|difference|NN =|=|SYM 0.10|0.10|CD g|g|NN ,|,|, 95|95|CD %|%|NN CI|ci|NN =|=|SYM 0.04|0.04|CD to|to|IN 0.16|0.16|CD ,|,|, P|p|NN =|=|SYM .001|.001|CD )|)|-RRB- (|(|-LRB- Figure|figure|NN 1|1|CD ,|,|, D|d|NN and|and|CC E|e|NN )|)|-RRB- .|.|. 
To|to|TO investigate|investigate|VB the|the|DT dependence|dependence|NN of|of|IN the|the|DT antitumor|antitumor|JJ effect|effect|NN on|on|IN the|the|DT expression|expression|NN of|of|IN endogenous|endogenous|JJ Fas|Fas|NNP in|in|IN the|the|DT host|host|NN ,|,|, we|we|PRP implanted|implant|VBD B16|b16|NN mouse|mouse|NN melanoma|melanoma|NN cells|cell|NNS into|into|IN C57|c57|NN /|/|HYPH B16|b16|NN mice|mouse|NNS with|with|IN wild|wild|JJ -|-|HYPH type|type|NN or|or|CC lpr|lpr|NN /|/|HYPH lpr|lpr|NN backgrounds|background|NNS .|.|. 
FasL|fasl|NN -|-|HYPH expressing|express|VBG S.|S.|NNP typhimurium|typhimurium|NN failed|fail|VBD to|to|TO inhibit|inhibit|VB B16|b16|NN tumor|tumor|NN growth|growth|NN in|in|IN lpr|lpr|NN /|/|HYPH lpr|lpr|NN -|-|HYPH mice|mouse|NNS ,|,|, which|which|WDT lack|lack|VBP Fas|Fas|NNP ,|,|, in|in|IN contrast|contrast|NN to|to|IN wild|wild|JJ -|-|HYPH type|type|NN control|control|NN mice|mouse|NNS .|.|. 
Mean|Mean|NNP tumor|tumor|NN volumes|volume|NNS were|be|VBD 1882|1882|CD mm3|mm3|NN for|for|IN PBS|pbs|NN (|(|-LRB- control|control|NN )|)|-RRB- -|-|HYPH treated|treat|VBN wildtype|wildtype|JJ mice|mouse|NNS vs|vs|IN 1761|1761|CD mm3|mm3|NN for|for|IN S.|S.|NNP typhimurium|typhimurium|NN --|--|: FasL|fasl|NN -|-|HYPH treated|treat|VBN lpr|lpr|NN /|/|HYPH lpr|lpr|NN mice|mouse|NNS (|(|-LRB- difference|difference|NN =|=|SYM 121|121|CD mm3|mm3|NN ,|,|, 95|95|CD %|%|NN CI|ci|NN =|=|SYM 811|811|CD mm3|mm3|NN to|to|IN 1053|1053|CD mm3|mm3|NN ,|,|, P|p|NN =|=|SYM .73|.73|CD )|)|-RRB- at|at|IN 22|22|CD days|day|NNS after|after|IN treatment|treatment|NN (|(|-LRB- Figure|figure|NN 2|2|CD ,|,|, B|b|NN )|)|-RRB- .|.|. 
Thus|thus|RB ,|,|, the|the|DT antitumor|antitumor|JJ activity|activity|NN of|of|IN FasL|fasl|NN -|-|HYPH expressing|express|VBG S.|S.|NNP typhimurium|typhimurium|NN depends|depend|VBZ at|at|IN least|least|JJS in|in|IN part|part|NN on|on|IN expression|expression|NN of|of|IN intact|intact|JJ Fas|Fas|NNP on|on|IN host|host|NN cells|cell|NNS rather|rather|RB than|than|IN tumor|tumor|NN cells|cell|NNS .|.|. 
It|it|PRP has|have|VBZ been|be|VBN previously|previously|RB demonstrated|demonstrate|VBN that|that|IN FasL|fasl|NN is|be|VBZ chemotactic|chemotactic|JJ for|for|IN neutrophils|neutrophil|NNS ,|,|, and|and|CC this|this|DT activity|activity|NN can|can|MD be|be|VB indispensable|indispensable|JJ for|for|IN efﬁcient|efﬁcient|NN inhibition|inhibition|NN of|of|IN tumor|tumor|NN growth|growth|NN under|under|IN some|some|DT circumstances|circumstance|NNS (|(|-LRB- 9|9|CD )|)|-RRB- .|.|. 
In|in|IN this|this|DT regard|regard|NN ,|,|, we|we|PRP observed|observe|VBD an|a|DT increase|increase|NN in|in|IN inﬂammatory|inﬂammatory|JJ cells|cell|NNS ,|,|, particularly|particularly|RB neutrophils|neutrophil|NNS ,|,|, within|within|IN subcutaneously|subcutaneously|RB grown|grow|VBN D2F2|d2f2|NN breast|breast|NN tumors|tumor|NNS in|in|IN mice|mouse|NNS treated|treat|VBN with|with|IN FasL|fasl|NN -|-|HYPH expressing|express|VBG S.|S.|NNP typhimurium|typhimurium|NN ,|,|, as|as|IN determined|determine|VBN by|by|IN hematox|hematox|NN -|-|HYPH ylin|ylin|NN and|and|CC eosin|eosin|NN staining|staining|NN and|and|CC by|by|IN immunohistochemistry|immunohistochemistry|NN using|use|VBG anti|anti|AFX --|--|: Ly|ly|NN -|-|HYPH 6G|6g|NN staining|staining|NN (|(|-LRB- Figure|figure|NN 2|2|CD ,|,|, A|a|DT and|and|CC Supplementary|supplementary|JJ Figure|figure|NN ,|,|, available|available|JJ online|online|RB )|)|-RRB- .|.|. 
To|to|TO experimentally|experimentally|RB investigate|investigate|VB the|the|DT role|role|NN of|of|IN neutrophils|neutrophil|NNS in|in|IN the|the|DT antitumor|antitumor|JJ activity|activity|NN of|of|IN FasL|fasl|NN -|-|HYPH expressing|express|VBG S.|S.|NNP typhimurium|typhimurium|NN ,|,|, we|we|PRP depleted|deplete|VBD neutrophils|neutrophil|NNS in|in|FW vivo|vivo|FW using|use|VBG an|a|DT anti|anti|AFX --|--|: Ly|ly|NN -|-|HYPH 6G|6g|NN antibody|antibody|NN (|(|-LRB- 20|20|CD )|)|-RRB- before|before|IN beginning|begin|VBG treatment|treatment|NN of|of|IN B16|b16|NN melanoma|melanoma|NN --|--|: bearing|bear|VBG mice|mouse|NNS with|with|IN FasL|fasl|NN -|-|HYPH expressing|express|VBG S.|S.|NNP typhimurium|typhimurium|NN (|(|-LRB- Figure|figure|NN 2|2|CD ,|,|, B|b|NN )|)|-RRB- .|.|. 
Tumor|tumor|NN weights|weight|NNS from|from|IN killed|kill|VBN mice|mouse|NNS showed|show|VBD that|that|IN the|the|DT antitumor|antitumor|JJ effects|effect|NNS of|of|IN targeted|target|VBN FasL|fasl|NN were|be|VBD abolished|abolish|VBN when|when|WRB neutro|neutro|NN -|-|HYPH phils|phil|NNS were|be|VBD depleted|deplete|VBN (|(|-LRB- mean|mean|VB tumor|tumor|NN weight|weight|NN for|for|IN mice|mouse|NNS treated|treat|VBN with|with|IN S.|S.|NNP typhimurium|typhimurium|NN --|--|: FasL|fasl|NN +|+|SYM anti|anti|AFX --|--|: Ly|ly|NN -|-|HYPH 6G|6g|NN =|=|SYM 1405|1405|CD mg|mg|NNS ,|,|, tumor|tumor|NN weight|weight|NN for|for|IN mice|mouse|NNS treated|treat|VBN with|with|IN S.|S.|NNP typhimurium|typhimurium|NN --|--|: FasL|fasl|NN in|in|IN Figure|figure|NN 2|2|CD .|.|. 
Roles|role|NNS of|of|IN neutrophils|neutrophil|NNS and|and|CC Fas|Fas|NNP in|in|IN observed|observe|VBN antitumor|antitumor|JJ effects|effect|NNS .|.|. 
A|a|NN )|)|-RRB- Accumulation|Accumulation|NNP of|of|IN neutro|neutro|NN -|-|HYPH phils|phil|NNS in|in|IN Fas|Fas|NNP ligand|ligand|NN (|(|-LRB- FasL|fasl|NN )|)|-RRB- --|--|: treated|treat|VBN D2F2|d2f2|NN breast|breast|NN tumors|tumor|NNS .|.|. 
Treated|treat|VBN and|and|CC untreated|untreated|JJ mice|mouse|NNS were|be|VBD killed|kill|VBN with|with|IN an|a|DT overdose|overdose|NN of|of|IN intraperitoneal|intraperitoneal|JJ Avertin|avertin|NN anesthetic|anesthetic|NN (|(|-LRB- 0.017|0.017|CD mL|ml|NN /|/|SYM g|g|NN body|body|NN weight|weight|NN ;|;|: Aldrich|Aldrich|NNP ,|,|, Milwaukee|Milwaukee|NNP ,|,|, WI|WI|NNP )|)|-RRB- followed|follow|VBN by|by|IN cervical|cervical|JJ dislocation|dislocation|NN .|.|. 
Tumor|tumor|NN tissues|tissue|NNS from|from|IN BALB|balb|NN /|/|HYPH c|c|NN mice|mouse|NNS (|(|-LRB- n|n|NN =|=|SYM 3|3|CD per|per|IN group|group|NN )|)|-RRB- were|be|VBD ﬁxed|ﬁxed|VBN in|in|IN paraformaldehyde|paraformaldehyde|NN ,|,|, embedded|embed|VBN in|in|IN parafﬁn|parafﬁn|NN ,|,|, and|and|CC subjected|subject|VBN to|to|IN histopathologic|histopathologic|JJ analyses|analysis|NNS using|use|VBG staining|staining|NN with|with|IN hematoxylin|hematoxylin|NN and|and|CC eosin|eosin|NN and|and|CC with|with|IN an|a|DT antibody|antibody|NN speciﬁc|speciﬁc|NN for|for|IN the|the|DT Ly|ly|NN -|-|HYPH 6G|6g|NN antigen|antigen|NN (|(|-LRB- BD|bd|NN ,|,|, Franklin|Franklin|NNP Lakes|Lakes|NNP ,|,|, NJ|NJ|NNP )|)|-RRB- .|.|. 
Shown|show|VBN are|be|VBP high|high|JJ -|-|HYPH power|power|NN ﬁeld|ﬁeld|NN examples|example|NNS (|(|-LRB- ×|×|SYM 400|400|CD magniﬁcation|magniﬁcation|NN )|)|-RRB- of|of|IN D2F2|d2f2|NN breast|breast|NN tumors|tumor|NNS from|from|IN mice|mouse|NNS treated|treat|VBN intravenously|intravenously|RB with|with|IN phosphate|phosphate|NN -|-|HYPH buffered|buffer|VBN saline|saline|NN (|(|-LRB- PBS|pbs|NN )|)|-RRB- ,|,|, S.|S.|NNP typhimurium|typhimurium|NN (|(|-LRB- Sal|Sal|NNP )|)|-RRB- ,|,|, S.|S.|NNP typhimurium|typhimurium|NN plus|plus|CC empty|empty|JJ vector|vector|NN (|(|-LRB- Sal|Sal|NNP +|+|SYM vector|vector|NN )|)|-RRB- ,|,|, or|or|CC S.|S.|NNP typhimurium|typhimurium|NN plus|plus|CC FasL|fasl|NN -|-|HYPH bearing|bearing|NN vector|vector|NN (|(|-LRB- Sal|Sal|NNP +|+|SYM FasL|FasL|NNP )|)|-RRB- .|.|. 
B|b|NN )|)|-RRB- Dependence|dependence|NN of|of|IN treatment|treatment|NN on|on|IN host|host|NN neutrophils|neutrophil|NNS and|and|CC Fas|Fas|NNP .|.|. 
C57|c57|NN /|/|HYPH Bl6|bl6|NN mice|mouse|NNS (|(|-LRB- n|n|NN =|=|SYM 5|5|CD per|per|IN group|group|NN )|)|-RRB- were|be|VBD injected|inject|VBN subcutaneously|subcutaneously|RB with|with|IN 105|105|CD B16|b16|NN murine|murine|JJ melanoma|melanoma|NN cells|cell|NNS .|.|. 
After|after|IN 7|7|CD days|day|NNS ,|,|, mice|mouse|NNS were|be|VBD injected|inject|VBN intravenously|intravenously|RB with|with|IN PBS|pbs|NN ,|,|, S.|S.|NNP typhimurium|typhimurium|NN (|(|-LRB- Sal|Sal|NNP )|)|-RRB- ,|,|, S.|S.|NNP typhimurium|typhimurium|NN plus|plus|CC empty|empty|JJ vector|vector|NN (|(|-LRB- Sal|Sal|NNP +|+|SYM vector|vector|NN )|)|-RRB- ,|,|, or|or|CC S.|S.|NNP typhimurium|typhimurium|NN plus|plus|CC FasL|fasl|NN -|-|HYPH bearing|bearing|NN vector|vector|NN (|(|-LRB- Sal|Sal|NNP +|+|SYM FasL|FasL|NNP )|)|-RRB- .|.|. 
Test|test|NN groups|group|NNS also|also|RB included|include|VBD mice|mouse|NNS treated|treat|VBN with|with|IN Sal|Sal|NNP +|+|SYM FasL|FasL|NNP 5|5|CD and|and|CC 15|15|CD days|day|NNS after|after|IN intraperitoneal|intraperitoneal|JJ treatment|treatment|NN with|with|IN 500|500|CD µg|µg|NN per|per|IN mouse|mouse|NN of|of|IN Ly|ly|NN -|-|HYPH 6G|6g|NN antibody|antibody|NN ,|,|, an|a|DT antibody|antibody|NN that|that|WDT depletes|deplete|VBZ neutrophils|neutrophil|NNS (|(|-LRB- Sal|Sal|NNP +|+|SYM FasL|fasl|NN +|+|SYM anti|anti|AFX --|--|: Ly|ly|NN -|-|HYPH 6G|6g|NN )|)|-RRB- ,|,|, and|and|CC C57|c57|NN /|/|HYPH Bl6|bl6|NN mice|mouse|NNS lacking|lack|VBG Fas|Fas|NNP (|(|-LRB- Sal|Sal|NNP +|+|SYM FasL|FasL|NNP in|in|IN lpr|lpr|NN mice|mouse|NNS )|)|-RRB- .|.|. 
Mice|mouse|NNS were|be|VBD killed|kill|VBN after|after|IN 22|22|CD days|day|NNS ,|,|, and|and|CC tumor|tumor|NN weights|weight|NNS were|be|VBD determined|determine|VBN (|(|-LRB- means|means|NNS with|with|IN 95|95|CD %|%|NN conﬁdence|conﬁdence|NN intervals|interval|NNS )|)|-RRB- .|.|. 
*|*|NFP P|p|NN <|<|SYM .05|.05|CD .|.|. 
Results|result|NNS are|be|VBP representative|representative|JJ of|of|IN three|three|CD independent|independent|JJ experiments|experiment|NNS .|.|. 
B16|b16|NN cells|cell|NNS were|be|VBD obtained|obtain|VBN from|from|IN ATCC|atcc|NN (|(|-LRB- Manassas|Manassas|NNP ,|,|, VA|VA|NNP )|)|-RRB- .|.|. 
Female|female|JJ C57|c57|NN /|/|HYPH Bl6|bl6|NN and|and|CC lpr|lpr|NN /|/|HYPH lpr|lpr|NN mice|mouse|NNS (|(|-LRB- 6|6|CD --|--|: 8|8|CD weeks|week|NNS of|of|IN age|age|NN )|)|-RRB- were|be|VBD supplied|supply|VBN by|by|IN The|the|DT Jackson|Jackson|NNP Laboratory|Laboratory|NNP (|(|-LRB- Bar|Bar|NNP Harbor|Harbor|NNP ,|,|, ME|ME|NNP )|)|-RRB- .|.|. 
1|1|LS .|.|. 
Thamm|Thamm|NNP DH|DH|NNP ,|,|, Kurzman|Kurzman|NNP ID|ID|NNP ,|,|, King|King|NNP I|I|PRP ,|,|, et|et|FW al.|al.|FW .|.|. 
Systemic|systemic|JJ administration|administration|NN of|of|IN an|a|DT attenuated|attenuate|VBN ,|,|, tumor|tumor|NN -|-|HYPH targeting|target|VBG Salmonella|salmonella|NN typhimurium|typhimurium|NN to|to|IN dogs|dog|NNS with|with|IN spontaneous|spontaneous|JJ neoplasia|neoplasia|NN :|:|: phase|phase|NN I|I|PRP evaluation|evaluation|NN .|.|. 
Clin|Clin|NNP Cancer|Cancer|NNP Res|Res|NNP .|.|. 
2005|2005|CD ;|;|: 11|11|CD (|(|-LRB- 13|13|CD )|)|-RRB- :|:|: 4827|4827|CD --|--|: 4834|4834|CD .|.|. 
2|2|LS .|.|. 
Rosenberg|Rosenberg|NNP SA|SA|NNP ,|,|, Spiess|Spiess|NNP PJ|PJ|NNP ,|,|, Kleiner|Kleiner|NNP DE|de|NN .|.|. 
Antitumor|Antitumor|NNP effects|effect|NNS in|in|IN mice|mouse|NNS of|of|IN the|the|DT intravenous|intravenous|JJ injection|injection|NN of|of|IN attenuated|attenuate|VBN Salmonella|salmonella|NN typhimur|typhimur|NN -|-|HYPH ium|ium|NN .|.|. 
J|j|NN Immunother|immunother|NN .|.|. 
2002|2002|CD ;|;|: 25|25|CD (|(|-LRB- 3|3|CD )|)|-RRB- :|:|: 218|218|CD --|--|: 225|225|CD .|.|. 
3|3|LS .|.|. 
Clairmont|Clairmont|NNP C|C|NNP ,|,|, Lee|Lee|NNP KC|KC|NNP ,|,|, Pike|Pike|NNP J|J|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Biodistribution|Biodistribution|NNP and|and|CC genetic|genetic|JJ stability|stability|NN of|of|IN the|the|DT novel|novel|JJ antitumor|antitumor|JJ agent|agent|NN VNP20009|vnp20009|NN ,|,|, a|a|DT genetically|genetically|RB modiﬁed|modiﬁed|VBN strain|strain|NN of|of|IN Salmonella|Salmonella|NNP typhimurium|typhimurium|NN .|.|. 
J|j|NN Infect|infect|NN Dis|dis|NN .|.|. 
2000|2000|CD ;|;|: 181|181|CD (|(|-LRB- 6|6|CD )|)|-RRB- :|:|: 1996|1996|CD --|--|: 2002|2002|CD .|.|. 
4|4|LS .|.|. 
Carrier|Carrier|NNP MJ|MJ|NNP ,|,|, Chatﬁeld|Chatﬁeld|NNP SN|SN|NNP ,|,|, Dougan|Dougan|NNP G|G|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Expression|expression|NN of|of|IN human|human|JJ IL|il|NN -|-|HYPH 1|1|CD beta|beta|NN in|in|IN Salmonella|Salmonella|NNP typhimurium|typhimurium|NN .|.|. 
A|a|DT model|model|NN system|system|NN for|for|IN the|the|DT delivery|delivery|NN of|of|IN recombinant|recombinant|JJ therapeutic|therapeutic|JJ proteins|proteins|NN in|in|FW vivo|vivo|FW .|.|. 
J|j|NN Immunol|immunol|NN .|.|. 
1992|1992|CD ;|;|: 148|148|CD (|(|-LRB- 4|4|CD )|)|-RRB- :|:|: 1176|1176|CD --|--|: 1181|1181|CD .|.|. 
5|5|CD .|.|. 
Thorburn|Thorburn|NNP A.|A.|NNP Death|Death|NNP receptor|receptor|NN -|-|HYPH induced|induce|VBN cell|cell|NN kill|kill|VB -|-|HYPH ing|ing|VBG .|.|. 
Cell|cell|NN Signal|Signal|NNP .|.|. 
2004|2004|CD ;|;|: 16|16|CD (|(|-LRB- 2|2|CD )|)|-RRB- :|:|: 139|139|CD --|--|: 144|144|CD .|.|. 
6|6|CD .|.|. 
Linkermann|Linkermann|NNP A|A|NNP ,|,|, Qian|Qian|NNP J|J|NNP ,|,|, Janssen|Janssen|NNP O.|O.|NNP Slowly|slowly|RB getting|get|VBG a|a|DT clue|clue|NN on|on|IN CD95|cd95|NN ligand|ligand|NN biology|biology|NN .|.|. 
Biochem|Biochem|NNP Pharmacol|Pharmacol|NNP .|.|. 
2003|2003|CD ;|;|: 66|66|CD (|(|-LRB- 8|8|CD )|)|-RRB- :|:|: 1417|1417|CD --|--|: 1426|1426|CD .|.|. 
7|7|CD .|.|. 
Rescigno|Rescigno|NNP M|M|NNP ,|,|, Piguet|Piguet|NNP V|V|NNP ,|,|, Valzasina|Valzasina|NNP B|B|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Fas|Fas|NNP engagement|engagement|NN induces|induce|VBZ the|the|DT maturation|maturation|NN of|of|IN dendritic|dendritic|JJ cells|cell|NNS (|(|-LRB- DCs|dc|NNS )|)|-RRB- ,|,|, the|the|DT release|release|NN of|of|IN interleukin|interleukin|NN (|(|-LRB- IL|il|NN )|)|-RRB- -1|-1|NN beta|beta|NN ,|,|, and|and|CC the|the|DT production|production|NN of|of|IN interferon|interferon|NN gamma|gamma|NN in|in|IN the|the|DT absence|absence|NN of|of|IN IL|il|NN -|-|HYPH 12|12|CD during|during|IN DC|DC|NNP -|-|HYPH T|T|NNP cell|cell|NN cognate|cognate|JJ interaction|interaction|NN :|:|: a|a|DT new|new|JJ role|role|NN for|for|IN Fas|Fas|NNP ligand|ligand|NN in|in|IN inﬂammatory|inﬂammatory|JJ responses|response|NNS .|.|. 
J|j|NN Exp|exp|NN Med|Med|NNP .|.|. 
2000|2000|CD ;|;|: 192|192|CD (|(|-LRB- 11|11|CD )|)|-RRB- :|:|: 1661|1661|CD --|--|: 1668|1668|CD .|.|. 
8|8|CD .|.|. 
Ottonello|Ottonello|NNP L|L|NNP ,|,|, Tortolina|Tortolina|NNP G|G|NNP ,|,|, Amelotti|Amelotti|NNP M|M|NNP ,|,|, Dallegri|Dallegri|NNP F.|F.|NNP Soluble|Soluble|NNP Fas|Fas|NNP ligand|ligand|NN is|be|VBZ chemotactic|chemotactic|JJ for|for|IN human|human|JJ neutrophilic|neutrophilic|JJ polymorphonuclear|polymorphonuclear|NN leukocytes|leukocyte|NNS .|.|. 
J|j|NN Immunol|immunol|NN .|.|. 
1999|1999|CD ;|;|: 162|162|CD (|(|-LRB- 6|6|CD )|)|-RRB- :|:|: 3601|3601|CD --|--|: 3606|3606|CD .|.|. 
9|9|LS .|.|. 
Arai|Arai|NNP H|H|NNP ,|,|, Gordon|Gordon|NNP D|D|NNP ,|,|, Nabel|Nabel|NNP EG|EG|NNP ,|,|, Nabel|Nabel|NNP GJ|GJ|NNP .|.|. 
Gene|gene|NN transfer|transfer|NN of|of|IN Fas|Fas|NNP ligand|ligand|NN induces|induce|VBZ tumor|tumor|NN regression|regression|NN in|in|FW vivo|vivo|FW .|.|. 
Proc|Proc|NNP Natl|Natl|NNP Acad|Acad|NNP Sci|Sci|NNP U|U|NNP S|S|NNP A.|A.|NNP 1997|1997|CD ;|;|: 94|94|CD (|(|-LRB- 25|25|CD )|)|-RRB- :|:|: 13862|13862|CD --|--|: 13867|13867|CD .|.|. 
10|10|CD .|.|. 
Kidoya|Kidoya|NNP H|H|NNP ,|,|, Umemura|Umemura|NNP M|M|NNP ,|,|, Kawabe|Kawabe|NNP T|T|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Fas|Fas|NNP ligand|ligand|NN induces|induce|VBZ cell|cell|NN -|-|HYPH autonomous|autonomous|JJ IL|il|NN -|-|HYPH 23|23|CD production|production|NN in|in|IN dendritic|dendritic|JJ cells|cell|NNS ,|,|, a|a|DT mechanism|mechanism|NN for|for|IN Fas|Fas|NNP ligand|ligand|NN -|-|HYPH induced|induce|VBN IL|il|NN -|-|HYPH 17|17|CD production|production|NN .|.|. 
J|j|NN Immunol|immunol|NN .|.|. 
2005|2005|CD ;|;|: 175|175|CD (|(|-LRB- 12|12|CD )|)|-RRB- :|:|: 8024|8024|CD --|--|: 8031|8031|CD .|.|. 
11|11|CD .|.|. 
Suzuki|Suzuki|NNP I|I|PRP ,|,|, Martin|Martin|NNP S|S|NNP ,|,|, Boursalian|boursalian|JJ TE|te|NN ,|,|, Beers|Beers|NNP C|C|NNP ,|,|, Fink|Fink|NNP PJ|PJ|NNP .|.|. 
Fas|Fas|NNP ligand|ligand|NN costimulates|costimulate|VBZ the|the|DT in|in|FW vivo|vivo|FW proliferation|proliferation|NN of|of|IN CD8|cd8|NN +|+|SYM T|t|NN cells|cell|NNS .|.|. 
J|j|NN Immunol|immunol|NN .|.|. 
2000|2000|CD ;|;|: 165|165|CD (|(|-LRB- 10|10|CD )|)|-RRB- :|:|: 5537|5537|CD --|--|: 5543|5543|CD .|.|. 
12|12|CD .|.|. 
Ogasawara|Ogasawara|NNP J|J|NNP ,|,|, Watanabe|Watanabe|NNP -|-|HYPH Fukunaga|Fukunaga|NNP R|R|NNP ,|,|, Adachi|Adachi|NNP M|M|NNP ,|,|, et|et|FW al.|al.|FW .|.|. 
Lethal|Lethal|NNP effect|effect|NN of|of|IN the|the|DT anti-Fas|anti-fas|JJ antibody|antibody|NN in|in|IN mice|mouse|NNS .|.|. 
Nature|Nature|NNP .|.|. 
1993|1993|CD ;|;|: 364:806|364:806|CD --|--|: 809|809|CD .|.|. 
Funding|fund|VBG NIH|NIH|NNP -|-|HYPH CA69381|ca69381|NN ;|;|: Austrian|austrian|JJ Program|program|NN for|for|IN Advanced|Advanced|NNP Research|Research|NNP and|and|CC Technology|Technology|NNP (|(|-LRB- Austrian|Austrian|NNP Academy|Academy|NNP of|of|IN Sciences|Sciences|NNPS )|)|-RRB- .|.|. 
Notes|note|NNS References|reference|NNS 
